Carcinoid syndromeSRIRAJASKANTHAN, R; SHANMUGABAVAN, D; RAMAGE, K et al.BMJ (Overseas and retired doctors ed.). 2010, Vol 341, Num 7773, pp 603-604, issn 1759-2151, 2 p.Article

The Glasgow Blatchford scoring system enables accurate risk stratification of patients with upper gastrointestinal haemorrhageSRIRAJASKANTHAN, R; CONN, R; BULWER, C et al.International journal of clinical practice (Esher). 2010, Vol 64, Num 7, pp 868-874, issn 1368-5031, 7 p.Article

Surgical management and palliative treatment in bronchial neuroendocrine tumours: A clinical study of 45 patientsSRIRAJASKANTHAN, R; TOUMPANAKIS, C; KARPATHAKIS, A et al.Lung cancer. 2009, Vol 65, Num 1, pp 68-73, issn 0169-5002, 6 p.Article

Lymphogranuloma venereum proctitis masquerading as inflammatory bowel disease in 12 homosexual menSONI, S; SRIRAJASKANTHAN, R; LUCAS, S. B et al.Alimentary pharmacology & therapeutics. 2010, Vol 32, Num 1, pp 59-65, issn 0269-2813, 7 p.Article

Review article : future therapies for management of metastatic gastroenteropancreatic neuroendocrine tumoursSRIRAJASKANTHAN, R; TOUMPANAKIS, C; MEYER, T et al.Alimentary pharmacology & therapeutics. 2009, Vol 29, Num 11, pp 1143-1154, issn 0269-2813, 12 p.Article

Expression of Somatostatin and Dopamine 2 Receptors in Neuroendocrine Tumours and the Potential Role for New BiotherapiesSRIRAJASKANTHAN, R; WATKINS, J; MARELLI, L et al.Neuroendocrinology (Basel). 2009, Vol 89, Num 3, pp 308-314, issn 0028-3835, 7 p.Article

Long-term results of patients with malignant carcinoid syndrome receiving octreotide LARTOUMPANAKIS, C; GARLAND, J; MARELLI, L et al.Alimentary pharmacology & therapeutics. 2009, Vol 30, Num 7, pp 733-740, issn 0269-2813, 8 p.Article

Review article: the investigation and management of gastric neuroendocrine tumoursBASUROY, R; SRIRAJASKANTHAN, R; PRACHALIAST, A et al.Alimentary pharmacology & therapeutics. 2014, Vol 39, Num 10, pp 1071-1084, issn 0269-2813, 14 p.Article

A review of thymic tumoursSRIRAJASKANTHAN, R; TOUBANAKIS, C; DUSMET, M et al.Lung cancer. 2008, Vol 60, Num 1, pp 4-13, issn 0169-5002, 10 p.Article

Α-Fetoprotein and human chorionic gonadotrophin-β as prognostic markers in neuroendocrine tumour patientsSHAH, T; SRIRAJASKANTHAN, R; WARNER, B et al.British journal of cancer. 2008, Vol 99, Num 1, pp 72-77, issn 0007-0920, 6 p.Article